Jade Biosciences Files Additional Proxy Materials
Ticker: JBIO · Form: DEFA14A · Filed: Apr 28, 2026 · CIK: 0001798749
| Field | Detail |
|---|---|
| Company | Jade Biosciences, Inc. (JBIO) |
| Form Type | DEFA14A |
| Filed Date | Apr 28, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, soliciting-materials, corporate-action
TL;DR
Jade Bio dropped more proxy docs for a deal, check the graphics.
AI Summary
Jade Biosciences, Inc. filed a Definitive Additional Materials (DEFA14A) on April 28, 2026. This filing includes additional soliciting materials related to a previously announced transaction. The filing contains graphic materials, suggesting visual aids were used in the solicitation process.
Why It Matters
This filing provides supplementary information to shareholders regarding a transaction, which is crucial for informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine filing of additional proxy materials and does not introduce new risks.
Key Players & Entities
- Jade Biosciences, Inc. (company) — Filer of the DEFA14A
- 0001193125-26-187069 (filing_id) — SEC Accession Number for the filing
- 2026-04-28 (date) — Filing Date
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, which stands for Definitive Additional Materials.
Who is the filer of this document?
The filer is Jade Biosciences, Inc. (CIK: 0001798749).
When was this filing submitted to the SEC?
The filing date was April 28, 2026.
What is the primary purpose of a DEFA14A filing?
A DEFA14A filing is used to provide additional soliciting materials to shareholders, often in relation to a previously announced transaction or meeting.
What other documents are included with this filing?
The filing includes a DEFA14A document, two graphic files (snap22.jpg and snap23.jpg), and a complete submission text file.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 28, 2026 regarding Jade Biosciences, Inc. (JBIO).